Trial Site Detail

 

Drug:
Masitinib, (AB1010)
Trial:
A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Center GH Diaconesses-Croix Saint Simon

     
Paris ,
France

 

Principal Investigator:
Isabelle Cojean-Zelek
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Center GH Diaconesses-Croix Saint Simon Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.